Ferring inks $500M deal with Royalty Pharma on new bladder cancer gene therapy kdunleavy Thu, 08/24/2023 – 10:17 More: Ferring inks 0M deal with Royalty Pharma on new bladder cancer gene therapy Source: fierce
read moreAfter high-profile snub, Akebia plots vadadustat resubmission at FDA fkansteiner Thu, 08/24/2023 – 09:47 More: After high-profile snub, Akebia plots vadadustat resubmission at FDA Source: fierce
read moreHorizon pips Roche to rare disease reputation crown as Pfizer falls off the leaderboard ntaylor Thu, 08/24/2023 – 08:00 More: Horizon pips Roche to rare disease reputation crown as Pfizer falls off the leaderboard Source: fierce
read moreThe drug is currently being assessed in a phase 1b/2a clinical trial More: FDA grants ODD to Nexcella's multiple myeloma treatment Source: News
read moreThe drug is the first to be approved in Japan to treat children and adolescents with generalised myasthenia gravis More: AstraZeneca’s Soliris approved in Japan for paediatric gMG patients Source: News
read moreAfter $1.7B opioid settlement, Mallinckrodt readies 2nd bankruptcy bid fkansteiner Wed, 08/23/2023 – 13:56 More: After .7B opioid settlement, Mallinckrodt readies 2nd bankruptcy bid Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals